|
|
Conditioning Regimens |
Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia |
1095 |
AP Jillella,
R Doria,
K Khan,
D Zelterman,
YH Ahmad,
BR Smith,
W Holmes,
P Becker,
KB Roberts & JM Rappeport
|
Abstract
Full Article (PDF)
|
|
Peripheral Blood Stem Cells |
Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC) |
1101 |
I Benet,
F Prosper,
I Marugan,
A Lluch,
C Arbona,
I Castillo,
C Solano & J Garcia-Conde
|
Abstract
Full Article (PDF)
|
|
Cord Blood Stem Cells |
Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells |
1109 |
T Fietz,
WE Berdel,
H Rieder,
B Reufi,
H Hopp,
E Thiel & WU Knauf
|
Abstract
Full Article (PDF)
|
|
Cytokines And Growth Factors |
Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantation |
1117 |
P Okunieff,
AJ Barrett,
SE Phang,
A Li,
LS Constine,
JP Williams,
P Rubin,
X Wang,
T Wu,
Y Chen & I Ding
|
Abstract
Full Article (PDF)
|
|
High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths |
1123 |
KS Baker,
M-G Roncarolo,
C Peters,
M Bigler,
T DeFor & BR Blazar
|
Abstract
Full Article (PDF)
|
|
Hodgkins Disease |
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkins disease |
1131 |
DE Reece,
TJ Nevill,
A Sayegh,
JJ Spinelli,
DA Brockington,
MJ Barnett,
H-G Klingemann,
JM Connors,
SH Nantel,
JD Shepherd,
HJ Sutherland,
NJS Voss,
RN Fairey,
SE OReilly & GL Phillips
|
Abstract
Full Article (PDF)
|
|
Graft-Versus-Host Disease |
Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin |
1139 |
L Weiss & S Slavin
|
Abstract
Full Article (PDF)
|
|
Pre-treatment of transplant bone marrow cells with hydrocortisone and cyclosporin A alleviates graft-versus-host reaction in a murine allogeneic host-donor combination |
1145 |
D Gr evi ,
D Batini ,
JL Ascensao & M Maru i
|
Abstract
Full Article (PDF)
|
|
Immunotherapy |
Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation |
1153 |
C Ibisch,
G Gallot,
R Vivien,
E Diez,
F Jotereau,
R Garand & H Vié
|
Abstract
Full Article (PDF)
|
|
Miscellaneous Complications |
Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation |
1161 |
RM Sobecks,
MM Le Beau,
J Anastasi & SF Williams
|
Abstract
Full Article (PDF)
|
|
Infections Post Transplant |
Opportunistic CNS infection after bone marrow transplantation |
1167 |
M Maschke,
U Dietrich,
M Prumbaum,
O Kastrup,
B Turowski,
UW Schaefer & HC Diener
|
Abstract
Full Article (PDF)
|
|
Using at least 5×106/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation |
1177 |
C Scheid,
A Draube,
M Reiser,
A Schulz,
J Chemnitz,
S Nelles,
M Fuchs,
S Winter,
PD Wickramanayake,
V Diehl & D Söhngen
|
Abstract
Full Article (PDF)
|
|
Murine Model |
A locus on chromosome 2 influences the development of acute graft-versus-host disease in a murine model |
1183 |
JM Harper,
DL Slayback,
JA Dobkins & RD Allen
|
Abstract
Full Article (PDF)
|
|
Technical Report |
Multicentre European study comparing selection techniques for the isolation of CD34+ cells |
1191 |
EA de Wynter,
D Ryder,
F Lanza,
G Nadali,
H Johnsen,
P Denning-Kendall,
B Thing-Mortensen,
F Silvestri & NG Testa
|
Abstract
Full Article (PDF)
|
|
Case Reports |
Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD) |
1197 |
B Gmeinhart,
W Hinterberger,
HT Greinix,
W Rabitsch,
R Kirnbauer,
E Reiter & B Volc-Platzer
|
Abstract
Full Article (PDF)
|
|
Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation |
1201 |
WY Au,
AKW Lie,
CK Lee,
R Liang & YL Kwong
|
Abstract
Full Article (PDF)
|
|
Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation |
1205 |
BU Müller,
A Tichelli,
JR Passweg,
C Nissen,
A Wodnar-Filipowicz & A Gratwohl
|
Abstract
Full Article (PDF)
|
|
Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy |
1209 |
S Chakrabarti,
KE Collingham,
CD Fegan & DW Milligan
|
Abstract
Full Article (PDF)
|
|
Erratum |
Case Report: Plasmodium vivax causing pancytopenia after allogeneic blood stem cell transplantation in CML |
1213 |
V Raina,
A Sharma,
S Gujral & R Kumar
|
Full Article (PDF)
|
|